Mental health

#AstraZeneca #Drug discovery #Europe #European Federation of Pharmaceutical Industries and Associations #FDA #Francis Crick Institute #Hypertension #Lung cancer #Mental health #Tropical disease #University of Dundee #Wellcome Trust

DDW Highlights: 26 May 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a report showed patients in Europe face barriers to medicine access. Elsewhere,… Read More

#Podcasts

#Mental health #Wellcome Trust

Wellcome and Nature launch $1m mental health science prize 

Wellcome has launched the world’s largest global prize for scientific breakthroughs in mental health.  The Wellcome Prize for Mental Health Science has been launched in a collaboration between charitable foundation Wellcome and scientific journal Nature, offering prizes up to $1 million.  The prize is open for applications from research… Read More

#News

Antibiotics
#Antibiotics #Mental health #Psychiatry #Schizophrenia

Antibiotic doxycycline shown to reduce schizophrenia risk

A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research suggests.  Experts found that patients of adolescent mental health services who were treated with the antibiotic doxycycline were significantly less likely to go on to develop schizophrenia in adulthood compared… Read More

#News

#Cell and gene therapy #Drug discovery #Mental health #National Institute for Health and Care Excellence (NICE)

This week in drug discovery 8-12 September

News round-up for 8-12 September by DDW Editor Reece Armstrong. Fast-track designations by the FDA, clinical trials to advance mental health and pharma team-ups to bring innovations to market are just some of the stories in this week’s news round-up. The top stories FDA fast-tracks Sanofi’s AMD gene therapy… Read More

#News

Patient speaking to psychiatrist
#Clinical trials #Mental health #Psychiatry #UK

First NHS-embedded clinical trial site for mental health launches

The UK’s first fully NHS-embedded commercial research for brain and mental health conditions has been launched by Clerkenwell Health.   Developed in partnership with Rotherham Doncaster and South Humber (RDaSH) NHS Foundation Trust, the initiative aims to set a new standard for how trials are delivered in the… Read More

#News

MHRA
#Biogen #Clinical trials #Mental health #MHRA #Regulatory #UK

Treatment for post-natal depression authorised in UK

The first targeted treatment for post-natal depression (PND) has been authorised for use in the UK through the approval of Biogen’s zuranolone by the Medicines and Healthcare Products Regulatory Agency (MHRA). Biogen state that the marketing authorisation by the MHRA addresses a critical, unmet need in maternal health due to… Read More

#News

Mental health concept
#Antidepressants #Gut-brain interaction #Mental health #Neuroscience

A promising new target for mental health

DDW Editor Reece Armstrong speaks to Kara Margolis, MD, Director of the NYU Pain Research Center and Associate Professor at NYU College of Dentistry and NYU Grossman School of Medicine, and Mark Ansorge, Associate Professor of clinical neurobiology at Columbia University about recent research highlighting the importance between the gut… Read More

#Exclusive Content

Magic Mushrooms in laboratory. Psilocybin science and research.
#Alcohol Use Disorder #Mental health #Oncology #Psilocybin #Psychedelics #Psychiatry

Findings support positive mental health benefits of psychedelics

One or two doses of psilocybin may improve the mental health of cancer patients when accompanied by psychotherapy, a new report suggests.   A second new study found that treatment with psilocybin resulted in lasting, positive personality changes in patients with alcohol use disorder.  In the… Read More

#News

The microbiome
#Gut microbiome #Mental health #Microbiome #Psychiatry

Can the gut microbiome unlock new therapeutics in mental health?

Janet Sasso and Rumiana Tenchov, Information Scientists at CAS, discuss the relationship between the gut microbiome and mental health, reporting on topics that CAS has explored over the recent years. The gut-brain axis (GBA), a signalling pathway connecting the gastrointestinal tract and the central nervous system, has increasingly been found… Read More

#Exclusive Content

Microbiome
#Drug development #Drug discovery #Mental health #Microbiome #Oncology

Hot off the press: Read the Fall issue of DDW now

The DDW Fall issue is out now and asks if the gut microbiome can unlock new therapeutics for mental health disorders, places a spotlight on oncology and includes a market report on the North American drug discovery hotspots. It also features an exclusive guide on… Read More

#Editor's Choice #News

Plant-based concept
#Bio Studio #Bioma #Chronic pain #Mental health #Plant-based #Start-ups

Tackling pain and mental health with plant-based medicines

DDW Editor Reece Armstrong speaks to Michael Krogh Jensen, Co-founder and CEO of Biomia, about developing plant-based medicines and what recent investment and support from the Bio Studio programme means for its pipeline. RA: How has being part of the Bio Studio programme helped you develop your pipeline? MJ: The… Read More

#Exclusive Content #Start-up Zone

Neuroscience innovation
#AI #Alzheimer's #Artificial intelligence (AI) #Biomarkers #Brain disease #Drug discovery #Inherited tauopathies #Mental health #Nervous system disorders #Neurodegenerative disorders #Neurology #Neuroscience #Neurotechnology #Psychiatry #Tau protein

New podcast on innovation in neuroscience

This is the latest episode of the free DDW narrated podcast, titled “Where is the latest innovation in neuroscience?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Taking a new approach to tackle neurodegenerative diseases,… Read More

#News

World Mental Health Day
#Depression #Drug discovery #Major depressive disorder #Mental health #Postpartum depression

World Mental Health Day 2023: Drug discovery breakthroughs

Over recent months, there have been a number of ground-breaking discoveries in drug discovery for mental health conditions. A new class of antidepressants In July 2023, AlzeCure Pharma published the results of a preclinical study supporting the antidepressive effects ACD856, the first in a new class… Read More

#Editor's Choice #News

Seed fund
#BioInnovation Institute #Financing #Mental health #Plant-based #Start-ups

$3M funding for plant-inspired halogenated small molecule drugs

Biomia, the first company spun out from BioInnovation Institute’s Bio Studio programme, has secured $3 million in pre-seed financing from an international syndicate of investors. Biomia says it plans to use the investment to accelerate its development of plant-inspired natural and new-to-nature halogenated small molecule drug candidates and further build… Read More

#Business & Investment #News #Start-up Zone

Patient speaking to psychiatrist
#FDA #Mental health #Postpartum depression #Sage Therapeutics

First oral drug for postpartum depression approved in US

The US Food and Drug Administration (FDA) has approved Sage Therapeutics’ Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. Until now, treatment for PPD was only available as an IV injection given by a health care provider in certain health care facilities. “Postpartum depression… Read More

#News #Regulatory

Mental health
#Antidepressants #Anxiety disorder #Depression #Drug discovery #Mental health #Neuroscience #Psychiatry

World Wellbeing Week 2023: Celebrating drug discovery innovation

DDW’s Diana Spencer provides an overview of the latest innovations in drug discovery for mental health. World Wellbeing Week was created to celebrate the many aspects of wellbeing, from meaningful, purposeful work to financial security, physical, mental and emotional health, social resilience and empathic corporate and civic leadership, community relations… Read More

#Exclusive Content